Anastomosing hemangioma: a current update on clinical, pathological and imaging features.

Autor: Shanbhogue K; Department of Radiology, NYU Langone Health, 660 1st Avenue, New York, NY, 10016, USA. Krishna.shanbhogue@nyulangone.org., Khandelwal A; Department of Radiology, Mayo Clinic, 200 First St, Rochester, MN, 55902, USA., Hajdu C; Department of Pathology, NYU Langone Health, 550 1st Avenue, New York, NY, 10016, USA., Cao W; Department of Pathology, NYU Langone Health, 550 1st Avenue, New York, NY, 10016, USA., Surabhi VR; Department of Radiology, The University of Texas MD Anderson Cancer Center, 1400 Pressler Street, Unit 1473, Houston, TX, 77030, USA., Prasad SR; Department of Radiology, The University of Texas MD Anderson Cancer Center, 1400 Pressler Street, Unit 1473, Houston, TX, 77030, USA.
Jazyk: angličtina
Zdroj: Abdominal radiology (New York) [Abdom Radiol (NY)] 2022 Jul; Vol. 47 (7), pp. 2335-2346. Date of Electronic Publication: 2022 Jun 09.
DOI: 10.1007/s00261-022-03559-5
Abstrakt: Anastomosing hemangioma (AH) is a rare, benign vascular neoplasm with distinctive histopathology and characteristic tumor distribution. AHs show marked proclivity to involve the kidneys, gonads and the retroperitoneal soft tissues; kidney is the most common target site often in the context of end stage renal disease. Recent studies have identified activating mutations of GNA genes that drive the molecular pathogenesis of AHs. AH appears as a solitary, well-circumscribed, hypervascular tumor that charters a benign course with an excellent prognosis. The purpose of this article is to provide a current update on clinical, pathological and imaging features of anastomotic hemangioma.
(© 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.)
Databáze: MEDLINE
Externí odkaz: